{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-030207","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2022-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.853367+00:00","generated_at":"2026-06-22T12:17:55.532250+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nephros Q3 net revenue $2.4M (-7% YoY); net loss widens to $1.3M; sells PDS business","bullets":["Net revenue from continuing operations $2.4M, down 7% vs Q3 2021; net loss $1.3M vs $0.8M.","Adjusted EBITDA loss from continuing operations -$0.3M, improving from -$0.4M in prior year.","Active Customer Sites grew 18% YoY to a record 1,391; price pull-ahead in Q2 hurt revenue.","Sold Pathogen Detection Systems (PDS) business; reduces quarterly expenses by ~$300K.","Cash and equivalents $3.9M at Sept 30, 2022; management targets positive cash flow by mid-2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-030207","json":"https://secwatch.observer/filing/0001493152-22-030207.json","markdown":"https://secwatch.observer/filing/0001493152-22-030207.md","text":"https://secwatch.observer/filing/0001493152-22-030207.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315222030207/0001493152-22-030207-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315222030207/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T12:17:55.532250+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8b99007ff958fcbbbcd226dde83911b93d676875","claim":"NEPHROS INC reported the third quarter ended September 30, 2022 results: revenue $2.4 million, net income $1.3 million.","evidence_excerpt":"Net revenue from continuing operations for the quarter ended September 30, 2022, was $2.4 million, compared to $2.6 million in the corresponding period in 2021, a decrease of 7%. Net loss from continuing operations for the quarter ended September 30, 2022, was $1.3 million, compared to $0.8 million during the same period in 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1196298/000149315222030207/0001493152-22-030207-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2022"},{"label":"Revenue","value":"$2.4 million"},{"label":"Net income","value":"$1.3 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}